DRE Final Knowledge Exam Practice Test
BankDrug Recognition Expert Certification | 150+
MCQs with Verified Answers & Detailed
RationalesNHTSA/IACP Aligned | 2026–2027
Edition
Section 1: DRE Program Foundations & Drug Scheduling (Questions 1–
25)
Q1. Which of the following best defines a "drug" according to the Federal
Food, Drug, and Cosmetic Act (FDCA)?
A. Any substance intended for the diagnosis, cure, mitigation, treatment, or
prevention of disease
B. Any article recognized in the official United States Pharmacopoeia
C. Any substance intended to affect the structure or function of the body
D. All of the above
Correct Answer: D. All of the above
Rationale: The FDCA defines a drug broadly to include articles intended for
diagnosis, cure, mitigation, treatment, or prevention of disease; articles
recognized in official compendia; and articles intended to affect the
structure or function of the body. This comprehensive definition is
foundational to DRE work.
,Q2. Which regulatory body is primarily responsible for approving new
prescription drugs in the United States?
A. DEA
B. FDA
C. CDC
D. OSHA
Correct Answer: B. FDA
Rationale: The Food and Drug Administration (FDA) is the federal agency
responsible for evaluating and approving new prescription drugs for safety
and efficacy before they can be marketed. The DEA handles controlled
substance scheduling, not drug approval.
Q3. A drug's generic name is best described as which of the following?
A. The proprietary name assigned by the manufacturer
B. The nonproprietary name approved by the FDA
C. The chemical name describing molecular structure
D. The brand name used in marketing
Correct Answer: B. The nonproprietary name approved by the FDA
Rationale: The generic name is the nonproprietary, official name of a drug
approved by the FDA and is not owned by any manufacturer. It is distinct
from the brand name (proprietary) and the chemical name.
Q4. Which phase of clinical trials primarily assesses a drug's safety and
dosage in a small number of healthy volunteers?
,A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: A. Phase I
Rationale: Phase I trials typically involve 20–80 healthy volunteers and focus
on safety, tolerability, and pharmacokinetics.
Q5. Which phase of clinical trials is designed to evaluate effectiveness and
monitor side effects in a larger patient population?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: C. Phase III
Rationale: Phase III trials involve large patient populations to confirm
efficacy, monitor side effects, and compare with standard treatments.
Q6. What is the purpose of a Phase IV post-marketing study?
A. To determine the chemical structure of a drug
B. To gather additional safety and efficacy data after approval
C. To test the drug in animals
D. To establish the starting dose for humans
, Correct Answer: B. To gather additional safety and efficacy data after
approval
Rationale: Phase IV studies are conducted after FDA approval to monitor
long-term safety, rare adverse effects, and effectiveness in real-world
populations.
Q7. Which of the following is a Schedule II controlled substance?
A. Heroin
B. Morphine
C. Alprazolam
D. Codeine with acetaminophen
Correct Answer: B. Morphine
Rationale: Morphine has a high potential for abuse and is classified as
Schedule II under the Controlled Substances Act. Heroin is Schedule I,
alprazolam is Schedule IV, and codeine combinations are typically Schedule
III–V.
Q8. Which DEA schedule has the highest potential for abuse and no
accepted medical use?
A. Schedule I
B. Schedule II
C. Schedule III
D. Schedule IV
Correct Answer: A. Schedule I
BankDrug Recognition Expert Certification | 150+
MCQs with Verified Answers & Detailed
RationalesNHTSA/IACP Aligned | 2026–2027
Edition
Section 1: DRE Program Foundations & Drug Scheduling (Questions 1–
25)
Q1. Which of the following best defines a "drug" according to the Federal
Food, Drug, and Cosmetic Act (FDCA)?
A. Any substance intended for the diagnosis, cure, mitigation, treatment, or
prevention of disease
B. Any article recognized in the official United States Pharmacopoeia
C. Any substance intended to affect the structure or function of the body
D. All of the above
Correct Answer: D. All of the above
Rationale: The FDCA defines a drug broadly to include articles intended for
diagnosis, cure, mitigation, treatment, or prevention of disease; articles
recognized in official compendia; and articles intended to affect the
structure or function of the body. This comprehensive definition is
foundational to DRE work.
,Q2. Which regulatory body is primarily responsible for approving new
prescription drugs in the United States?
A. DEA
B. FDA
C. CDC
D. OSHA
Correct Answer: B. FDA
Rationale: The Food and Drug Administration (FDA) is the federal agency
responsible for evaluating and approving new prescription drugs for safety
and efficacy before they can be marketed. The DEA handles controlled
substance scheduling, not drug approval.
Q3. A drug's generic name is best described as which of the following?
A. The proprietary name assigned by the manufacturer
B. The nonproprietary name approved by the FDA
C. The chemical name describing molecular structure
D. The brand name used in marketing
Correct Answer: B. The nonproprietary name approved by the FDA
Rationale: The generic name is the nonproprietary, official name of a drug
approved by the FDA and is not owned by any manufacturer. It is distinct
from the brand name (proprietary) and the chemical name.
Q4. Which phase of clinical trials primarily assesses a drug's safety and
dosage in a small number of healthy volunteers?
,A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: A. Phase I
Rationale: Phase I trials typically involve 20–80 healthy volunteers and focus
on safety, tolerability, and pharmacokinetics.
Q5. Which phase of clinical trials is designed to evaluate effectiveness and
monitor side effects in a larger patient population?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer: C. Phase III
Rationale: Phase III trials involve large patient populations to confirm
efficacy, monitor side effects, and compare with standard treatments.
Q6. What is the purpose of a Phase IV post-marketing study?
A. To determine the chemical structure of a drug
B. To gather additional safety and efficacy data after approval
C. To test the drug in animals
D. To establish the starting dose for humans
, Correct Answer: B. To gather additional safety and efficacy data after
approval
Rationale: Phase IV studies are conducted after FDA approval to monitor
long-term safety, rare adverse effects, and effectiveness in real-world
populations.
Q7. Which of the following is a Schedule II controlled substance?
A. Heroin
B. Morphine
C. Alprazolam
D. Codeine with acetaminophen
Correct Answer: B. Morphine
Rationale: Morphine has a high potential for abuse and is classified as
Schedule II under the Controlled Substances Act. Heroin is Schedule I,
alprazolam is Schedule IV, and codeine combinations are typically Schedule
III–V.
Q8. Which DEA schedule has the highest potential for abuse and no
accepted medical use?
A. Schedule I
B. Schedule II
C. Schedule III
D. Schedule IV
Correct Answer: A. Schedule I
